𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pioglitazone and vitamin E for nonalcoholic steatohepatitis: A cost utility analysis

✍ Scribed by Mahady, Suzanne E.; Wong, Germaine; Craig, Jonathan C.; George, Jacob

Book ID
118759136
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
526 KB
Volume
56
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A pilot study of pioglitazone treatment
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
✍ Kittichai Promrat; Glen Lutchman; Gabriel I. Uwaifo; Renee J. Freedman; Alejandr πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 146 KB πŸ‘ 2 views

Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease for which there is no known effective therapy. A proportion of patients with NASH progress to advanced fibrosis and cirrhosis. NASH is considered one of the clinical features of the metabolic syndrome in which insulin resistance p

Vitamin E for nonalcoholic steatohepatit
Vitamin E for nonalcoholic steatohepatitis: Ready for prime time?
✍ Jean-FranΓ§ois F. Dufour πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 222 KB

BACKGROUND: Nonalcoholic steatohepatitis is a common liver disease that can progress to cirrhosis. Currently, there is no established treatment for this disease. METHODS: We randomly assigned 247 adults with nonalcoholic steatohepatitis and without diabetes to receive pioglitazone at a dose of 30 mg